• no-js

The mission of the MRC Weatherall Institute of Molecular Medicine (WIMM) is to undertake internationally competitive research into the processes underlying normal cell and molecular biology and to determine the mechanisms by which these processes are perturbed in inherited and acquired human diseases. It is also our mission to translate this research to improve human health. The WIMM is uniquely placed among biomedical institutes throughout the world in its pioneering vision of combining outstanding clinical research with excellent basic science. The WIMM Faculty currently includes an equal mixture of scientists and clinicians working together and in collaboration with the National Institute of Health Research, the NHS and commercial companies with the aim of improving the diagnosis and treatment of human diseases. The major topics of current research include haematology, immunology, stem cell biology, oncology and inherited human genetic diseases. The Institute benefits from strategic support from the MRC.

MRC logo

The Institute values communication with members of the broader scientific community and the general public and with the support of the Medical Research Council (MRC) we have commissioned three short videos to explain our mission.

News

Wellcome Trust Postdoctoral Fellowship awarded

Wellcome Trust Postdoctoral Fellowship awarded

Posted 04/06/2015

Dr Beth Psaila has been awarded a Wellcome Trust Postdoctoral Fellowship. Beth will work with Adam Mead and Irene Roberts on the role of megakaryocytes in myelofibrosis (MF), using single cell profiling to study the molecular mechanisms underlying abnormal megakaryopoiesis in MF and the pathways by which megakaryocytes contribute to bone marrow fibrosis. She will spend the first 2 years of her Fellowship working in David Bodine's lab at the ...

 

WIMM PhD students reach the final of international biotech startup competition

WIMM PhD students reach the final of international biotech startup competition

Posted 11/05/2015

Bridging the divide between academia and industry is the sacred goal of many researchers, but few are equipped to take their ideas from the bench to the boardroom. However, OneStart (an initiative supported by the Oxbridge Biotech Roundtable and SR One - the corporate venture capital arm of GSK) is designed to help scientists do just that, and a team of four PhD students from Tudor Fulga’s lab have made it to the final of this year’s hotly ...

 News Archive

 

Vacancies

Computational / Bioinformatic Genomic Analyst ref: 119073

Posted 26/06/2015

A full-time position is available until 31 March 2017 in the first instance, for an experienced computational/bioinformatic genomics analyst to be responsible for analysis of complex biological datasets involving next generation sequence data (RNA, DNA, Chip-Seq, ATAC-Seq). Funding has been provided through the Oxford Biomedical Research Centre (BRC). This is an exciting project on the cutting edge of translational genomics and biomedical ...

Further Vacancies

WIMM Blog

Why one cell is better than 40,000,000,000,000

dnasequencing1
Your body is a mass of millions and millions of tiny building blocks called cells, which all work together seamlessly on a daily basis in order to allow you to eat, drink, sleep, work, consume caffeine and perform all other essential bodily functions. A major outstanding question in the biological sciences is how these cells behave individually, but until recently scientists have not been able to isolate and analyse these tiny tiny entities on their own. However, huge technological advances in recent years mean that finally this is now possible, and in this blog post Martin Larke explains how scientists at the WIMM plan to use these new methods to ask previously unanswerable questions.

WIMM Blog Archive